Abstract

Key points Loss‐of‐function mutations in proteins found at glycinergic synapses, most commonly in the α1 subunit of the glycine receptor (GlyR), cause the startle disease/hyperekplexia channelopathy in man.It was recently proposed that the receptors responsible are presynaptic homomeric GlyRs, rather than postsynaptic heteromeric GlyRs (which mediate glycinergic synaptic transmission), because heteromeric GlyRs are less affected by many startle mutations than homomers.We examined the α1 startle mutation S270T, at the extracellular end of the M2 transmembrane helix.Recombinant heteromeric GlyRs were less impaired than homomers by this mutation when we measured their response to equilibrium applications of glycine.However, currents elicited by synaptic‐like millisecond applications of glycine to outside‐out patches were much shorter (7‐ to 10‐fold) in all mutant receptors, both homomeric and heteromeric. Thus, the synaptic function of heteromeric receptors is likely to be impaired by the mutation. Human startle disease is caused by mutations in glycine receptor (GlyR) subunits or in other proteins associated with glycinergic synapses. Many startle mutations are known, but it is hard to correlate the degree of impairment at molecular level with the severity of symptoms in patients. It was recently proposed that the disease is caused by disruption in the function of presynaptic homomeric GlyRs (rather than postsynaptic heteromeric GlyRs), because homomeric GlyRs are more sensitive to loss‐of‐function mutations than heteromers. Our patch‐clamp recordings from heterologously expressed GlyRs characterised in detail the functional consequences of the α1S270T startle mutation, which is located at the extracellular end of the pore lining M2 transmembrane segment (18ʹ). This mutation profoundly decreased the maximum single‐channel open probability of homomeric GlyRs (to 0.16; cf. 0.99 for wild type) but reduced only marginally that of heteromeric GlyRs (0.96; cf. 0.99 for wild type). However, both heteromeric and homomeric mutant GlyRs became less sensitive to the neurotransmitter glycine. Responses evoked by brief, quasi‐synaptic pulses of glycine onto outside‐out patches were impaired in mutant receptors, as deactivation was approximately 10‐ and 7‐fold faster for homomeric and heteromeric GlyRs, respectively. Our data suggest that the α1S270T mutation is likely to affect the opening step in GlyR activation. The faster decay of synaptic currents mediated by mutant heteromeric GlyRs is expected to reduce charge transfer at the synapse, despite the high equilibrium open probability of these mutant channels.

Highlights

  • Glycine receptors mediate fast inhibitory synaptic transmission in the brainstem and spinal cord, where they are essential for motor control (Lynch, 2004)

  • We studied the effects on human recombinant homomeric and heteromeric glycine receptor (GlyR) of the naturally occurring mutation α1S270T, which is known to cause dominantly inherited startle disease/hyperekplexia in man (Lapunzina et al 2003)

  • We show here that the function of mutant GlyR was rescued by β subunit co-expression only in equilibrium measurements of glycine efficacy

Read more

Summary

Introduction

Glycine receptors mediate fast inhibitory synaptic transmission in the brainstem and spinal cord, where they are essential for motor control (Lynch, 2004). Comparable speeding up of the synaptic current decay has been described for glycinergic currents in spinal slices from mice with the spasmodic mutation (Graham et al 2006), and in artificial glycinergic synapses in culture, where the postsynaptic GlyRs are heterologously expressed to have a defined composition (Zhang et al 2015). Despite this agreement between molecular and cellular results, the severity of symptoms in patients or in transgenic mice is but poorly correlated with the degree of loss-of-function at receptor level and with the reduction in charge transfer expected at glycinergic synapses. The picture is made more complex by the demonstration that hyperekplexia can be caused by some (relatively mild) gain-of-function mutations in the α1 subunit (Zhang et al 2016)

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.